slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 102,421-102,450
Pages 3,953
Rows per page 30
Component
102,421-102,450 of 118,578
09
The slide uses a process diagram to illustrate the mechanism of action for REQORSA gene therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · NeedLoop · Golden Circle1 hit
10
The process is presented as a sequential workflow.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
15
ONC-001 TrialGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
17
The trial met Simon 2-stage criteria but was discontinued to prioritize a study with Tagrisso.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
18
The slide uses a 'problem-solution' framing, highlighting the limitation of existing drugs and the mechanism of the company's therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
19
The slide includes a timeline of the study and two line charts showing tumor volume over time for different treatment groups.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
The slide outlines a multi-phase clinical trial structure (Phase 1, 2a, 2b) and provides specific patient counts and interim analysis milestones.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
23
The table highlights a statistically significant difference (p=0.0008) in TUSC2 protein expression between SCLC and NSCLC.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
25
Kaplan-Meier survival curve showing PFS. Mentions Tecentriq as brand name for Atezolizumab.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
27
The slide shows four separate bar charts comparing Control, Atezo (Tecentriq), REQORSA, and Combination therapies across four immune cell types.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
28
Clinical trial design slide for a pharmaceutical study.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
29
The chart shows statistical significance (p-values) comparing treatment groups against controls.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
30
The chart shows tumor volume over time (days) for four groups, demonstrating synergistic efficacy of the dual gene therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
31
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
33
Uses an emotional image of a father and child to emphasize the human impact of the disease.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
39
The slide uses a comparative analogy between mouse lifespan and human lifespan to suggest long-term efficacy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
40
The slide uses a combination of a process description (left) and experimental data (line chart and bar chart) to validate the therapeutic hypothesis.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
41
NHP = Non-Human Primate. STZ likely refers to Streptozotocin, a compound used to induce diabetes in animal models.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
42
ATTD likely refers to the Advanced Technologies & Treatments for Diabetes conference.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
45
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
47
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
52
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
55
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
56
Includes bioluminescence imaging of tumor xenografts and bar charts quantifying Active T cells, MDSC, Active NK cells, and DC populations.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
58
The slide outlines the progression of a clinical trial from Phase 1 through Phase 2b.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations 1 hit
06
The slide uses a background image of ocean plastic pollution to establish emotional context.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
23
The slide uses a simple additive visual (Grove + HumanCo) to illustrate a strategic M&A framework.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
Includes footnotes for data sources.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
01
Includes company logo and update timing context.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations 1 hit
05
Honest | Investor Presentation Deck | 36 slidesHonest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Problem1 hit